About

OTClistings.com has been developed for the purpose of assisting the social media market for public companies. We pride ourselves in developing strategies based around building relationships, identifying target markets and viewers, and mediums such as twitter, facebook, youtube, linkedin, and your own personal blog to pull them all together.

We integrate the writing skills of experts in identifying quality companies from all industries and analysing their disclosed information and performance overall. OTCListings.com is enabled to have relevant quality content and an active audience. We have been actively working on a new project based on blogs for public companies and interactive Social Media. Whichever exchange you have a public company on, we will brand and load a blog software, twitter, facebook, etc, and automate it to run off your press releases. 
 
We initially want to set it up for free, and then in 30 days if you like the project, we have a monthly hosting fee, etc. If you want to make a lot of exposure and followers, OTCListings and its parent company Amalgamated Enterprises Inc have more intense programs, but they all are based on integrating social media, posting, links, twitter, facebook, youtube, etc. In the US, the SEC just recently recognized these mediums as appropriate REG FD for full disclosure mediums in addition to the website. Also, blogs can be used for e-proxy, I have written a bit about it on www.otclistings.com, this project is in a beta stage, but I wanted to invite you to be one of the companies. We own the rights to every domain for every exchange in the world “listings” and would be interested in loading companies from other markets in the same fashion. The positive part, is that you will be linked into all of the websites from the begining, which means that over time you will get the most traffic.

I hope you enjoy reading our blogs, if you are interested in us updating a release on your company or setting up a social media campaign please contact info@otclistings.com

Leave a Reply